A detailed history of Blackhawk Capital Partners Llc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Blackhawk Capital Partners Llc. holds 3,151 shares of AZN stock, worth $224,477. This represents 0.13% of its overall portfolio holdings.

Number of Shares
3,151
Holding current value
$224,477
% of portfolio
0.13%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$76.67 - $87.62 $241,587 - $276,090
3,151 New
3,151 $245,000
Q4 2018

Feb 04, 2019

SELL
$36.86 - $41.49 $240,658 - $270,888
-6,529 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$34.76 - $39.72 $226,948 - $259,331
6,529 New
6,529 $258,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $221B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Blackhawk Capital Partners Llc. Portfolio

Follow Blackhawk Capital Partners Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blackhawk Capital Partners Llc., based on Form 13F filings with the SEC.

News

Stay updated on Blackhawk Capital Partners Llc. with notifications on news.